A consideration when interpreting outpatient data - 10/08/11
Doi : 10.1016/j.jaad.2010.11.058
Tushar S. Dabade, MD a, ⁎ 
, Steven R. Feldman, MD, PhD a, b, c
, Steven R. Feldman, MD, PhD a, b, c a Center for Dermatology Research, Department of Dermatology, Wake Forest University School of Medicine Winston-Salem, North Carolina
b Center for Dermatology Research, Department of Pathology, Wake Forest University School of Medicine Winston-Salem, North Carolina
c Center for Dermatology Research, Department of Public Health Sciences, Wake Forest University School of Medicine Winston-Salem, North Carolina
Correspondence to: Tushar S. Dabade, MD, Department of Dermatology, Wake Forest University School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157-1071
Il testo completo di questo articolo è disponibile in PDF.
| The Center for Dermatology Research is supported by an unrestricted educational grant from Galderma Laboratories, L.P. |
|
| Dr Feldman has received research, speaking and/or consulting support from Galderma, Abbott Labs, Warner Chilcott, Aventis Pharmaceuticals, 3M, Connetics, Roche, Amgen, Biogen, Genentech, and Stiefel/GSK. Dr Dabade has no conflicts to declare. |
© 2010
American Academy of Dermatology, Inc.. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Vol 64 - N° 6
P. 1180-1181 - giugno 2011 Ritorno al numero
Articolo precedente
- Cutaneous collagenous vasculopathy
- Jean Kanitakis
- Hair care practices and scalp/hair disease in African American girls
- Nonhlanhla P. Khumalo
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?